Hair Health Blog

Dandruff can change how the roots and scalp look, but flakes alone do not explain why hair appears thinner. Gentle care and steady tracking can help.

Minoxidil is the comparator in nearly every hair trial. Why it holds that position, what its evidence base does and does not establish, and how the newer compounds line up...

A scalp hydrogel label should tell you what is in the formula, how to use it, who made it, and what cautions apply. Here is how to read the small...

Veradermics reported Phase 2/3 results in 519 men and Phase 2 results in 49 adults. What each study measured, the safety questions, and what is pending.

The Sheffield 2DDR work began with a 2024 animal paper. This guide explains its design, measures, evidence stage, and firm limits.

PP405 targets follicle metabolism rather than hormones. What the UCLA science says, what Phase 1 and Phase 2a measured, and why the 31% figure needs context.

A plain-language guide to saying 2-deoxy-D-ribose and understanding the shorter name 2DDR.

Clascoterone completed two Phase 3 trials in 1,465 men. A look at the trial lineage, what each phase measured, and why the two Phase 3 results differ.

A simple way to fit Deoxylocks into a morning scalp routine without turning the bathroom counter into a project.

A plain-English look at what Deoxylocks is, how it fits around colour, washing and styling, and the questions women most often ask before trying it.

2DDR and deoxyribose are related but not identical. A plain-English look at what the name means, how it relates to DNA, and why spellings differ.

Clascoterone, PP405 and VDPHL01 all reported trial results. Here is what each study measured, what stage it is at, and what the numbers do not say.